PIPENZOLATE METHYL BROMIDE
Pipenzolate Methyl Bromide is a medication belonging to the anticholinergic class, primarily used to treat gastrointestinal conditions by reducing smooth muscle spasms.It is indicated for the relief of symptoms associated with gastrointestinal spasms and hypermotility, such as irritable bowel syndrome and functional gastrointestinal disorders.
-The typical dosage of pipenzolate methyl bromide varies depending on the severity of symptoms and patient response. It is usually administered orally, with dosages adjusted according to individual needs and medical advice. -5-10 mg (2-3 mg in children daily in divided doses.
Pipenzolate methyl bromide is contraindicated in patients with known hypersensitivity to anticholinergic drugs or any component of the formulation. It should also be avoided in patients with glaucoma, obstructive uropathy, paralytic ileus, severe ulcerative colitis, and myasthenia gravis.
Special precautions should be taken when prescribing pipenzolate methyl bromide to elderly patients and those with impaired renal or hepatic function. Caution is advised during activities requiring mental alertness, as the medication may cause drowsiness or blurred vision.
Common side effects may include dry mouth, constipation, urinary retention, blurred vision, and tachycardia. Serious adverse reactions such as hallucinations, confusion, or severe allergic reactions are rare but possible.
Pipenzolate methyl bromide may interact with other medications such as certain antibiotics, antifungals, and medications with anticholinergic effects. Concurrent use with these drugs may increase the risk of adverse effects.
| Brand Name | Manufactured by |
|---|---|
| PIPEN | KOPRAN LTD. |
